cgp 52411 has been researched along with pd 153035 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchdunger, E; Furet, P; Lydon, N; Mett, H; Meyer, T; Traxler, PM | 1 |
| Borgers, S; Hagmann, W | 1 |
| Klar, U; Lichtner, RB; Menrad, A; Schneider, MR; Sommer, A | 1 |
3 other study(ies) available for cgp 52411 and pd 153035
| Article | Year |
|---|---|
4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase.
Topics: 3T3 Cells; Adenosine Triphosphate; Animals; Antineoplastic Agents; Binding Sites; Computer-Aided Design; Drug Design; Enzyme Inhibitors; ErbB Receptors; Genes, fos; Growth Inhibitors; Mice; Models, Molecular; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Pyrimidines; Signal Transduction; Structure-Activity Relationship | 1996 |
Requirement for epidermal growth factor receptor tyrosine kinase and for 12-lipoxygenase activity in the expression of 12-lipoxygenase in human epidermoid carcinoma cells.
Topics: Arachidonate 12-Lipoxygenase; Biotin; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Down-Regulation; ErbB Receptors; Humans; Lipoxygenase Inhibitors; Phalloidine; Phthalimides; Quinazolines; RNA, Messenger; Tumor Cells, Cultured | 1997 |
Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Division; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Gefitinib; Humans; Kinetics; Ligands; Lung Neoplasms; Mammary Neoplasms, Experimental; Phthalimides; Quinazolines; Rats; Signal Transduction; Tumor Cells, Cultured | 2001 |